Author Information
Diamantis I. Tsilimigras is affiliated with the Molecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. His research primarily focuses on various aspects of oncology, particularly hepatocellular carcinoma and other liver-related diseases.Research Contributions
In 2022, Diamantis I. Tsilimigras made significant contributions to the field of oncology through various research papers. His work encompasses a broad range of topics, including immune checkpoint inhibitor therapy for hepatocellular carcinoma, the impact of tumor necrosis on prognosis for patients undergoing liver resection, and the use of machine learning to stratify prognosis relative to tumor burden. Additionally, he has explored the effects of social vulnerability on perioperative risk in hepatopancreatic surgery and developed real-time mortality risk calculators following pancreatoduodenectomy.Aliases
Diamantis I. Tsilimigras is also known by several aliases, including Diamantis Tsilimigras, D. Tsilimigras, D. I. Tsilimigras, and D.i. Tsilimigras.Publication and Citation Metrics
| Metric |
Value |
| Total Citation Count |
5661 |
| H-index |
38 |
| Total Paper Count |
398 |
